Finance

Lists
NH:NSE
Narayana Hrudayalaya Ltd
1 717,30 INR
+1,30%
(+22,00) 1D
9-окт., 15:30:02 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NH...
Open
1 693,00 INR
High
1 746,30 INR
Low
1 693,00 INR
Mkt. cap
348,63 млд
Avg. vol.
217,04 миң
Volume
151,19 миң
Dividend
0,26%
Quarterly dividend
1,12 INR
Ex-dividend date
2026-ж., 17-июл.
P/E ratio
42,70
52-wk high
2 093,30 INR
52-wk low
1 589,00 INR
EPS
40,22 INR
Shares outstanding
204,36 млн
No. of employees
11 миң
Open
1 693,00 INR
High
1 746,30 INR
Low
1 693,00 INR
Mkt. cap
348,63 млд
Avg. vol.
217,04 миң
Volume
151,19 миң
Dividend
0,26%
Quarterly dividend
1,12 INR
Ex-dividend date
2026-ж., 17-июл.
P/E ratio
42,70
52-wk high
2 093,30 INR
52-wk low
1 589,00 INR
EPS
40,22 INR
Shares outstanding
204,36 млн
No. of employees
11 миң
News stories
From web sources and news partners
Profile
Narayana Health is an Indian for-profit private hospital network headquartered in Bangalore. It was founded by Dr. Devi Shetty in the year 2000. It operates several hospitals and heart centres across major Indian cities Bangalore, Delhi, Gurugram, Kolkata, Ahmedabad, Raipur, Jaipur, Mumbai, Mysore etc. with an international subsidiary in the Cayman Islands. The facilities offer medical care in over 30 medical specialties and three of its hospitals – Narayana Institute of Cardiac Sciences, Bangalore, and Health City Cayman Islands – are JCI accredited. Wikipedia
About Narayana Hrudayalaya Ltd
CEOEmmanuel Rupert
Employees11,2 миң
Founded2000
HeadquartersБенгалуру, Карнатака, Индия
SectorHealth care provider
Last report
2026-ж., 3-авг.
Fiscal period
Q1 2027
10,20 INR / 11,93 INR
-14,53%miss
Revenue / Est. (INR)
26,84 млд / 26,38 млд
+1,74%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
16,44 млд
21,51 млд
25,94 млд
26,84 млд
Cost of goods sold
8,76 млд
11,99 млд
18,24 млд
15,66 млд
Cost of revenue
8,76 млд
11,99 млд
18,24 млд
15,66 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
2,56 млд
-
Operating expense
4,53 млд
7,07 млд
4,14 млд
8,04 млд
Total operating expenses
13,29 млд
19,06 млд
22,38 млд
23,70 млд
Operating income
3,15 млд
2,45 млд
3,56 млд
3,14 млд
Other non operating income
239,92 млн
232,06 млн
-498,95 млн
354,76 млн
EBT including unusual items
2,95 млд
1,50 млд
2,92 млд
2,60 млд
EBT excluding unusual items
2,95 млд
2,01 млд
2,80 млд
2,60 млд
Income tax expense
371,93 млн
222,70 млн
641,07 млн
531,19 млн
Effective tax rate
12,59%
14,81%
21,94%
20,40%
Other operating expenses
3,65 млд
5,85 млд
38,10 млн
6,48 млд
Net income
2,58 млд
1,27 млд
2,24 млд
2,07 млд
Net profit margin
15,72%
5,89%
8,63%
7,72%
Earnings per share
12,71
8,45
11,22
10,20
Interest and investment income
-
-
594,31 млн
-
Interest expense
-422,60 млн
-650,33 млн
-912,85 млн
-868,01 млн
Net interest expenses
-422,60 млн
-650,33 млн
-318,54 млн
-868,01 млн
Depreciation and amortization charges
874,76 млн
1,22 млд
1,54 млд
1,56 млд
EBITDA
4,01 млд
3,01 млд
4,45 млд
4,03 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору